Dr. Koenig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Ste. 1535
Houston, TX 77030Phone+1 713-500-7164Fax+1 713-500-0719
Summary
- Board certified child neurologist specializing in neurodegenerative disorders including mitochondrial disease and tuberous sclerosis complex.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Child Neurology, 2004 - 2007
University of Texas Medical Branch HospitalsResidency, Pediatrics, 2002 - 2004
St. George's University School of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2010 - 2025
NY State Medical License 2008 - 2011- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Topical Rapamycin to Erase Angiofibromas in TSC Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 99 citationsPOLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disordersRussell P. Saneto, Inn Chi Lee, Mary Kay Koenig, Xinhua Bao, Shao Wen Weng
Seizure. 2010-04-01 - 268 citationsUpdated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.Hope Northrup, Mary E. Aronow, E. Martina Bebin, John Bissler, Thomas N. Darling
Pediatric Neurology. 2021-07-24 - 148 citationsMitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.Deborah E. Meyers, Haseeb Ilias Basha, Mary Kay Koenig
Texas Heart Institute Journal. 2013-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
